These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8584308)

  • 21. Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91.
    Andrus JK; Strebel PM; de Quadros CA; Olivé JM
    Bull World Health Organ; 1995; 73(1):33-40. PubMed ID: 7704923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New insights into physiopathology of immunodeficiency-associated vaccine-derived poliovirus infection; systematic review of over 5 decades of data.
    Shaghaghi M; Soleyman-Jahi S; Abolhassani H; Yazdani R; Azizi G; Rezaei N; Barbouche MR; McKinlay MA; Aghamohammadi A
    Vaccine; 2018 Mar; 36(13):1711-1719. PubMed ID: 29478755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of provocation poliomyelitis in vaccine-associated poliomyelitis.
    Ehrengut W
    Acta Paediatr Jpn; 1997 Dec; 39(6):658-62. PubMed ID: 9447753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Imported vaccine-associated paralytic poliomyelitis--United States, 2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Feb; 55(4):97-9. PubMed ID: 16456525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccine-associated paralytic poliomyelitis in oral polio vaccine recipients: disproportionality analysis using VAERS and systematic review.
    Suares JE; Khan S; Aadrika A; Poojari PG; Rashid M; Thunga G
    Expert Opin Drug Saf; 2024 Jul; 23(7):855-867. PubMed ID: 38813942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The occurrence of vaccine-associated paralytic poliomyelitis in Brazil, 1995 to 2001].
    Teixeira-Rocha ES; Carmo EH; Tavares-Neto J
    Rev Panam Salud Publica; 2005 Jul; 18(1):21-4. PubMed ID: 16105322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule.
    Miller MA; Sutter RW; Strebel PM; Hadler SC
    JAMA; 1996 Sep; 276(12):967-71. PubMed ID: 8805731
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poliovirus vaccine options.
    Zimmerman RK; Spann SJ
    Am Fam Physician; 1999 Jan; 59(1):113-8, 125-6. PubMed ID: 9917578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A developing country perspective on vaccine-associated paralytic poliomyelitis.
    John TJ
    Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MRI findings in an infant with vaccine-associated paralytic poliomyelitis.
    Ferraz-Filho JR; dos Santos Torres U; de Oliveira EP; Souza AS
    Pediatr Radiol; 2010 Dec; 40 Suppl 1():S138-40. PubMed ID: 20440488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccine associated paralytic poliomyelitis.
    Mittal SK; Mathew JL
    Indian J Pediatr; 2003 Jul; 70(7):573-7. PubMed ID: 12940380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of vaccine-associated paralytic poliomyelitis.
    Edwards EA; Grant CC; Huang QS; Powell KF; Croxson MC
    J Paediatr Child Health; 2000 Aug; 36(4):408-11. PubMed ID: 10940185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Childhood immunizations: position on the enhanced inactivated poliovirus vaccine and live attenuated oral poliovirus vaccine dilemma.
    Willis E; Sherrod JL
    J Natl Med Assoc; 1997 Dec; 89(12):785-9. PubMed ID: 9433057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Poliomyelitis prevention: revised recommendations for use of inactivated and live oral poliovirus vaccines. American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 1999 Jan; 103(1):171-2. PubMed ID: 9917460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurological morbidity in vaccine-associated paralytic poliomyelitis in Brazil from 1989 up to 1995.
    Dias-Tosta E; Kückelhaus CS
    Arq Neuropsiquiatr; 2004 Jun; 62(2B):414-20. PubMed ID: 15273837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The maintaining of the active laboratory-based surveillance of the acute flaccid paralysis (AFP) cases in Romania in the framework of the strategic plan of the global polio eradication initiative.
    Băicuş A; Persu A; Combiescu M; Aubert-Combiescu A
    Roum Arch Microbiol Immunol; 2007; 66(1-2):44-50. PubMed ID: 18928063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intramuscular injections and vaccine-associated poliomyelitis.
    Sepkowitz S
    N Engl J Med; 1995 Jul; 333(1):64. PubMed ID: 7777003
    [No Abstract]   [Full Text] [Related]  

  • 38. Vaccine-associated paralytic poliomyelitis in an infant with perianal abscesses.
    Higashigawa M; Maegawa K; Honma H; Yoshino A; Onozato K; Nashida Y; Fujiwara T; Inoue M
    J Infect Chemother; 2010 Oct; 16(5):356-9. PubMed ID: 20449625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaccine-associated paralytic poliomyelitis and BCG-osis in an immigrant child with severe combined immunodeficiency syndrome - Texas, 2013.
    Trimble R; Atkins J; Quigg TC; Burns CC; Wallace GS; Thomas M; Mangla AT; Infante AJ;
    MMWR Morb Mortal Wkly Rep; 2014 Aug; 63(33):721-4. PubMed ID: 25144542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outbreak of poliomyelitis due to type 3 poliovirus, northern India, 1999-2000: injections a major contributing factor.
    Kohler KA; Hlady WG; Banerjee K; Sutter RW
    Int J Epidemiol; 2003 Apr; 32(2):272-7. PubMed ID: 12714548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.